Water Street Healthcare Partners Announces Appointment of David Johnston

Whats Happening:

Water Street Healthcare Partners, a healthcare-focused investment fund, has appointed David M. Johnston, Ph.D., to its team. Johnston, a biopharmaceutical industry veteran, joins Water Street after a successful career at Thermo Fisher Scientific, where he led the contract research organization, PPD. He will work with Water Street's team to engage with pharmaceutical services and life science businesses interested in achieving next-level growth and value creation.

Key Moves:

• David M. Johnston, Ph.D., joins Water Street Healthcare Partners

• Johnston to focus on pharmaceutical services and life science businesses

• Water Street expands its presence in the pharmaceutical and life science sector

By The Numbers:

• Water Street has completed more than 70 transactions in pharmaceutical services

• The fund has built 48+ companies contributing to improved patient care

• Water Street has completed more than 165 investments and acquisitions

Key Quotes:

• "I'm excited to work with Water Street's team to advance our shared mission of building businesses that will make meaningful impacts in the pharmaceutical and life science sector, and most importantly, have a positive impact on patient care." - David Johnston

• "It's a dynamic time in our industry with new therapeutic modalities and digital technologies creating opportunities for innovation and growth." - David Johnston

Bottom Line:

The appointment of David Johnston strengthens Water Street's expertise in pharmaceutical services and life sciences. His extensive experience in clinical research and leadership in the industry aligns with Water Street's strategy to build market-leading businesses in critical healthcare sectors. This move is likely to enhance the fund's ability to identify and capitalize on growth opportunities in the rapidly evolving pharmaceutical and life science landscape.

Read Full Article